atropine has been researched along with glyceraldehyde in 1 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (glyceraldehyde) | Trials (glyceraldehyde) | Recent Studies (post-2010) (glyceraldehyde) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 1,161 | 1 | 167 |
| Protein | Taxonomy | atropine (IC50) | glyceraldehyde (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 0.01 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biden, TJ; Browne, CL | 1 |
1 other study(ies) available for atropine and glyceraldehyde
| Article | Year |
|---|---|
Cross-talk between muscarinic- and adenosine-receptor signalling in the regulation of cytosolic free Ca2+ and insulin secretion.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adenosine; Atropine; Calcium; Calcium Channels; Carbachol; Cells, Cultured; Colforsin; Cytosol; Enzyme Activation; Glyceraldehyde; Insulin; Insulin Secretion; Ion Channel Gating; Muscarinic Antagonists; Receptors, Muscarinic; Receptors, Purinergic; Signal Transduction; Type C Phospholipases | 1993 |